Detalhe da pesquisa
1.
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease.
Rheumatology (Oxford)
; 62(SI): SI43-SI53, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640959
2.
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.
Rheumatology (Oxford)
; 62(5): 1870-1876, 2023 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111858
3.
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
N Engl J Med
; 380(26): 2518-2528, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112379
4.
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON.
Ann Rheum Dis
; 81(12): 1722-1729, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973804
5.
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial.
Rheumatology (Oxford)
; 61(11): 4397-4408, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150246
6.
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.
Rheumatology (Oxford)
; 61(10): 4035-4046, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35238334
7.
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects.
Respir Res
; 23(1): 178, 2022 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35790961
8.
Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database.
Ann Rheum Dis
; 80(2): 219-227, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32988845
9.
Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.
Rheumatology (Oxford)
; 60(4): 1915-1925, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33155024
10.
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial.
Ann Rheum Dis
; 79(11): 1478-1484, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32759258
11.
Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by Bredemeier.
Ann Rheum Dis
; 81(12): e251, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023957
12.
Gammaherpesviruses and canine lymphoma: no evidence for direct involvement in commonly occurring lymphomas.
J Gen Virol
; 96(Pt 7): 1863-72, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25722346
13.
Basal Ganglia Calcification: A Case Report of Two Siblings With Fahr's Disease.
Cureus
; 16(2): e53434, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314389
14.
Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis.
BMC Rheumatol
; 8(1): 19, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773593
15.
Neurosyphilis-Induced Folie À Deux: A Case of Prolonged Psychosis.
Cureus
; 15(10): e46375, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37920639
16.
Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial.
Arthritis Care Res (Hoboken)
; 75(12): 2501-2507, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37357024
17.
Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression.
RMD Open
; 9(1)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796874
18.
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis.
Arthritis Res Ther
; 24(1): 19, 2022 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35012623
19.
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.
ACR Open Rheumatol
; 4(10): 837-844, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852465
20.
Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
Arthritis Rheumatol
; 74(3): 518-526, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34514739